Clinical trial

Asian Diabetes Outcomes Prevention Trial

NCT04286399

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2019-07-01

PhasePHASE4

Study timeline

Study start (actual)2019-07-01Date precision: day

Registry last updated2021-04-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitusunresolved

Cardiovascular Diseasesunresolved

Interventions

Renin-angiotensin-aldosterone system inhibitorsDRUG

Beta blockerDRUG

SGLT2 Inhibitor - Sodium Glucose Cotransporter Subtype 2 Inhibitor ProductDRUG

Sponsors & collaborators

National Heart Centre Singaporelead sponsor

Singapore General Hospitalcollaborator

Mackay Memorial Hospitalcollaborator

National Taiwan University Hospitalcollaborator

Peking University People's Hospitalcollaborator

Medanta, The Medicity, Indiacollaborator

Public Health Foundation of Indiacollaborator

Putrajaya Hospital, Malaysiacollaborator

Universiti Teknologi Maracollaborator

Mapped research locations

SingaporeSingapore1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04286399 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.